Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pulmonary Surfactant (PS)
- Target
- PS
- Molecular classification
- Lipoprotein Complex, Lipid Mixture, Phospholipid Mixture, Surfactant Protein A, Surfactant Protein B, Surfactant Protein C, Surfactant Protein D
01
Overview
Pulmonary surfactant is a complex mixture of lipids and proteins that lines the alveoli of the lungs. It reduces surface tension, prevents alveolar collapse, and facilitates gas exchange. It also plays a role in host defense and immune modulation. Deficiency or dysfunction of pulmonary surfactant is implicated in various lung diseases, including neonatal RDS and ARDS. Surfactant replacement therapy is used to treat neonatal RDS.
- Other names
- Lung SurfactantAlveolar Surfactant
02
Mechanism of action
Reduction of alveolar surface tension
03
Biological functions
Reduction of surface tensionPrevention of alveolar collapseMaintenance of lung complianceFacilitation of gas exchangeHost defenseImmune modulationLipid homeostasis
04
Disease associations
Neonatal Respiratory Distress Syndrome (RDS)Adult Respiratory Distress Syndrome (ARDS)AsthmaChronic Obstructive Pulmonary Disease (COPD)PneumoniaIdiopathic Pulmonary Fibrosis (IPF)Cystic FibrosisSarcoidosisHypersensitivity PneumonitisPulmonary edema
05
Safety considerations
Potential for barotrauma with excessive ventilation during surfactant administrationRisk of pulmonary hemorrhageAdverse immune reactions (rare)
06
Interacting drugs
Exogenous Surfactants (e.g., Beractant, Calfactant, Poractant alfa)
07
Biomarkers
Phosphatidylglycerol (PG) levels in amniotic fluid (for fetal lung maturity)Surfactant protein levels in bronchoalveolar lavage fluid (BALF) (for lung injury)
Beyond the preview
Go deeper on Pulmonary Surfactant (PS).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pulmonary Surfactant (PS).